71. M. Aboudzadeh, Y. Fazaeli, H. Khodaverdi, H. Afarideh, Production, nano-purification,
radiolabeling and biodistribution study of (
140
Nd) 5, 10, 15, 20-tetraphenylporphyrin complex
as a possible imaging agent. J. Radioanal. Nucl. Chem. 295(1), 105–113 (2013)
72. N. Vahidfar, A.R. Jalilian, Y. Fazaeli, A. Bahrami-Samani, D. Beiki, A. Khalaj, Development
and evaluation of a
166
holmium labelled porphyrin complex as a possible therapeutic agent.
J. Radioanal. Nucl. Chem. 295(2), 979–986 (2013)
73. H.D. Sarma, T. Das, S. Banerjee, M. Venkatesh, P.B. Vidyasagar, K.P. Mishra, Studies on
efficacy of a novel
177
Lu-labeled porphyrin derivative in regression of tumors in mouse
model. Curr. Radiopharm. 4(2), 150–160 (2011)
74. J. Crudo, M. Edreira, E. Obenaus, S. de Castiglia, Labeling of the anti-melanoma 14f7
monoclonal antibody with rhenium-188-MAG3 chelate: conjugation optimization, in vitro
stability and animal studies. J. Radioanal. Nucl. Chem. 261(2), 337–342 (2004)
75. K.M. Kadish, K.M. Smith, R. Guilard, Handbook of Porphyrin Science (World Scientific,
Singapore, 2010), pp. 1–35 2014
76. S. Banerjee, T. Das, G. Samuel, H. Sarma, M. Venkatesh, M. Pillai, A novel (
186/188 Re)labelled porphyrin for targeted radiotherapy. Nucl. Med. Commun. 22(10), 1101–1107 (2001)
77. H.D. Sarma, T. Das, S. Banerjee, M. Venkatesh, P.B. Vidyasagar, K.P. Mishra, Biologic
evaluation of a novel
188
Re-labeled porphyrin in mice tumor model. Cancer Biother.
Radiopharm. 25(1), 47–54 (2010)
78. Z. Jia, H. Deng, M. Pu, Synthesis and preliminary biological studies of the novel conjugate
188
Re-labeled meso-tetrakis (4-sulfophenyl) porphyrin in mice. Nucl. Med. Biol. 34(6), 643–
649 (2007)
79. Jia Z-y, Pu Deng H-f, Luo S-z M-f, Rhenium-188 labelled meso-tetrakis (3, 4-bis
(carboxymethyleneoxy) phenyl) porphyrin for targeted radiotherapy: preliminary biological
evaluation in mice. Eur. J. Nucl. Med. Mol. Imaging 35(4), 734–742 (2008)
80. E.R. Ranyuk, N. Cauchon, H. Ali, R. Lecomte, B. Guérin, J.E. van Lier, PET imaging using
64
Cu-labeled sulfophthalocyanines: synthesis and biodistribution. Bioorg. Med. Chem. Lett.
21(24), 7470–7473 (2011)
81. Y. Zhang, M. Jeon, L.J. Rich, H. Hong, J. Geng, Y. Zhang et al., Non-invasive multimodal
functional imaging of the intestine with frozen micellar naphthalocyanines. Nat. Nanotechnol.
9(8), 631–638 (2014)
82. M. Obochi, R. Boyle, Lier J. Van, Biological activities of phthalocyanines. XIII. The effects
of human serum components on the in vitro uptake and photodynamic activity of zinc
phthalocyanine. Photochem. Photobiol. 57(4), 634–640 (1993)
83. J. Rousseau, R. Boyle, A. MacLennan, T. Truscott, J. Van Lier, Biodistribution and tumor
uptake of (
67
Ga) chlorogallium-tetraoctadecyloxy phthalocyanine and its sulfonation products
in tumor bearing C3H mice. Int. J. Rad. Appl. Instrum. B. 18(7), 777–782 (1991)
84. J. Rousseau, D. Autenrieth, J.E. Van Lier, Synthesis, tissue distribution and tumor uptake of
(
99
Tc) tetrasulfophthalocyanine. Int. J. Appl. Radiat. Isot. 34(3), 571–579 (1983)
85. C.P. Gros, A. Eggenspiller, A. Nonat, J.-M. Barbe, F. Denat, New potential bimodal imaging
contrast agents based on DOTA-like and porphyrin macrocycles. Med. Chem. Commun. 2(2),
119–125 (2011)
86. B. Laster, S. Kahl, J. Kalef-Ezra, E. Popenoe, R.G. Fairchild, Biological Efficacy of a
Boronated Porphyrin as Measured in Cell Culture (Brookhaven National Lab, Upton, NY
(USA), 1987)
87. F. Benard, S. Kudrevich, J. Rousseau, J. van Lier, Radiolabeled phthalocyanines as tumor
imaging agents. Clin. Nucl. Med. 21(6), 512 (1996)
88. D.K. Lavallee, R. Fawwaz, The synthesis and characterization of 111 in hematoporphyrin
derivative. Int. J. Rad. Appl. Instrum. B 13(6), 639–641 (1986)
89. D.W. Wong, A simple and efficient method of labeling hematoporphyrin derivative with
111
In. Appl. Radiat. Isot. 35(7), 691–692 (1984)
3 Porphyrin and Phthalocyanine Radiolabeling
77
radiolabeling and biodistribution study of (
140
Nd) 5, 10, 15, 20-tetraphenylporphyrin complex
as a possible imaging agent. J. Radioanal. Nucl. Chem. 295(1), 105–113 (2013)
72. N. Vahidfar, A.R. Jalilian, Y. Fazaeli, A. Bahrami-Samani, D. Beiki, A. Khalaj, Development
and evaluation of a
166
holmium labelled porphyrin complex as a possible therapeutic agent.
J. Radioanal. Nucl. Chem. 295(2), 979–986 (2013)
73. H.D. Sarma, T. Das, S. Banerjee, M. Venkatesh, P.B. Vidyasagar, K.P. Mishra, Studies on
efficacy of a novel
177
Lu-labeled porphyrin derivative in regression of tumors in mouse
model. Curr. Radiopharm. 4(2), 150–160 (2011)
74. J. Crudo, M. Edreira, E. Obenaus, S. de Castiglia, Labeling of the anti-melanoma 14f7
monoclonal antibody with rhenium-188-MAG3 chelate: conjugation optimization, in vitro
stability and animal studies. J. Radioanal. Nucl. Chem. 261(2), 337–342 (2004)
75. K.M. Kadish, K.M. Smith, R. Guilard, Handbook of Porphyrin Science (World Scientific,
Singapore, 2010), pp. 1–35 2014
76. S. Banerjee, T. Das, G. Samuel, H. Sarma, M. Venkatesh, M. Pillai, A novel (
186/188 Re)labelled porphyrin for targeted radiotherapy. Nucl. Med. Commun. 22(10), 1101–1107 (2001)
77. H.D. Sarma, T. Das, S. Banerjee, M. Venkatesh, P.B. Vidyasagar, K.P. Mishra, Biologic
evaluation of a novel
188
Re-labeled porphyrin in mice tumor model. Cancer Biother.
Radiopharm. 25(1), 47–54 (2010)
78. Z. Jia, H. Deng, M. Pu, Synthesis and preliminary biological studies of the novel conjugate
188
Re-labeled meso-tetrakis (4-sulfophenyl) porphyrin in mice. Nucl. Med. Biol. 34(6), 643–
649 (2007)
79. Jia Z-y, Pu Deng H-f, Luo S-z M-f, Rhenium-188 labelled meso-tetrakis (3, 4-bis
(carboxymethyleneoxy) phenyl) porphyrin for targeted radiotherapy: preliminary biological
evaluation in mice. Eur. J. Nucl. Med. Mol. Imaging 35(4), 734–742 (2008)
80. E.R. Ranyuk, N. Cauchon, H. Ali, R. Lecomte, B. Guérin, J.E. van Lier, PET imaging using
64
Cu-labeled sulfophthalocyanines: synthesis and biodistribution. Bioorg. Med. Chem. Lett.
21(24), 7470–7473 (2011)
81. Y. Zhang, M. Jeon, L.J. Rich, H. Hong, J. Geng, Y. Zhang et al., Non-invasive multimodal
functional imaging of the intestine with frozen micellar naphthalocyanines. Nat. Nanotechnol.
9(8), 631–638 (2014)
82. M. Obochi, R. Boyle, Lier J. Van, Biological activities of phthalocyanines. XIII. The effects
of human serum components on the in vitro uptake and photodynamic activity of zinc
phthalocyanine. Photochem. Photobiol. 57(4), 634–640 (1993)
83. J. Rousseau, R. Boyle, A. MacLennan, T. Truscott, J. Van Lier, Biodistribution and tumor
uptake of (
67
Ga) chlorogallium-tetraoctadecyloxy phthalocyanine and its sulfonation products
in tumor bearing C3H mice. Int. J. Rad. Appl. Instrum. B. 18(7), 777–782 (1991)
84. J. Rousseau, D. Autenrieth, J.E. Van Lier, Synthesis, tissue distribution and tumor uptake of
(
99
Tc) tetrasulfophthalocyanine. Int. J. Appl. Radiat. Isot. 34(3), 571–579 (1983)
85. C.P. Gros, A. Eggenspiller, A. Nonat, J.-M. Barbe, F. Denat, New potential bimodal imaging
contrast agents based on DOTA-like and porphyrin macrocycles. Med. Chem. Commun. 2(2),
119–125 (2011)
86. B. Laster, S. Kahl, J. Kalef-Ezra, E. Popenoe, R.G. Fairchild, Biological Efficacy of a
Boronated Porphyrin as Measured in Cell Culture (Brookhaven National Lab, Upton, NY
(USA), 1987)
87. F. Benard, S. Kudrevich, J. Rousseau, J. van Lier, Radiolabeled phthalocyanines as tumor
imaging agents. Clin. Nucl. Med. 21(6), 512 (1996)
88. D.K. Lavallee, R. Fawwaz, The synthesis and characterization of 111 in hematoporphyrin
derivative. Int. J. Rad. Appl. Instrum. B 13(6), 639–641 (1986)
89. D.W. Wong, A simple and efficient method of labeling hematoporphyrin derivative with
111
In. Appl. Radiat. Isot. 35(7), 691–692 (1984)
3 Porphyrin and Phthalocyanine Radiolabeling
77